COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
by Melissa Merrell Rhoads, PharmD, PCCA Director of Formulations We introduced our proprietary base, Lipoderm® (PCCA #30-3338), in the early 2000s. Now recognized as the first proprietary permeation-enhancing vehicle in the compounding industry, Lipoderm has since become an official USP Compounded Preparation Monograph for Ondansetron Compounded Topical Gel (20 mg/mL).
Our product innovations, however, did not end there. We subsequently introduced a family of Lipoderm permeation-enhancing bases that are scientifically proven to deliver active pharmaceutical ingredients (APIs) through the skin, as indicated by an ever-growing portfolio of peer-reviewed journal publications and FormulaPlus™ BUD-studied formulas.
The Lipoderm Family of Bases
Our Lipoderm family of products expands your options for topical compounded permeation-enhancing preparations to address the needs of your patients.
Lipoderm® (PCCA #30-3338) is great for general permeation-enhancing and deep-penetrating topical formulations.
Lipoderm ActiveMax® (PCCA #30-4482) is an excellent base for APIs with high-salt concentrations.
Lipoderm® HMW™ (PCCA #30-4612) works well for APIs with high molecular weights.
Anhydrous Lipoderm® (PCCA #30-4283) is perfect for APIs that are unstable in water.
Compounding Preparations